Biomedtracker and Datamonitor interviewed a psychiatry/neurology specialist based in the US to determine his views on pipeline drugs that were presented at the 2016 Alzheimer’s Association International Conference (AAIC), including LMTX, anti-beta amyloid monoclonal antibodies, Anavex 2-73, and PF-05212377.

If you are a KOL Insight Subscriber, please access the interview from our KOL Insight portal (Subscribers only).

Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.

For our disclosures, please read the Biomedtracker Research Standards.